PAPER Merrill DA, Siddarth P, Kepe V, Raja PV, Saito N, Ercoli LM, Miller KJ, Lavretsky H, Bookheimer SY, Barrio JR, Small GW
SEARCH RESULTS
330988 RESULTS
PAPER Walton JR
Aluminum involvement in the progression of Alzheimer's disease.
J Alzheimers Dis. 2013 Jan 1;35(1):7-43. PubMed: 23380995PAPER Park L, Zhou J, Zhou P, Pistick R, El Jamal S, Younkin L, Pierce J, Arreguin A, Anrather J, Younkin SG, Carlson GA, McEwen BS, Iadecola C
Innate immunity receptor CD36 promotes cerebral amyloid angiopathy.
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3089-94. PubMed: 23382216PAPER Maulik M, Thinakaran G, Kar S
Alterations in gene expression in mutant amyloid precursor protein transgenic mice lacking Niemann-Pick type C1 protein.
PLoS One. 2013;8(1):e54605. PubMed: 23382922PAPER Parthsarathy V, McClean PL, Hölscher C, Taylor M, Tinker C, Jones G, Kolosov O, Salvati E, Gregori M, Masserini M, Allsop D
A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.
PLoS One. 2013;8(1):e54769. PubMed: 23382963PAPER Guo L, Du H, Yan S, Wu X, McKhann GM, Chen JX, Yan SS
Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer's neurons.
PLoS One. 2013;8(1):e54914. PubMed: 23382999PAPER Teich AF, Patel M, Arancio O
A reliable way to detect endogenous murine β-amyloid.
PLoS One. 2013;8(2):e55647. PubMed: 23383341PAPER Zhong XM, Hou L, Luo XN, Shi HS, Hu GY, He HB, Chen XR, Zheng D, Zhang YF, Tan Y, Liu XJ, Mu N, Chen JP, Ning YP
Alterations of CSF cystatin C levels and their correlations with CSF Αβ40 and Αβ42 levels in patients with Alzheimer's disease, dementia with lewy bodies and the atrophic form of general paresis.
PLoS One. 2013;8(1):e55328. PubMed: 23383156PAPER Santana S, Rico EP, Burgos JS
Can zebrafish be used as animal model to study Alzheimer's disease?
Am J Neurodegener Dis. 2012;1(1):32-48. PubMed: 23383380PAPER Sparks DL, Kryscio RJ, Sabbagh MN, Ziolkowski C, Lin Y, Sparks LM, Liebsack C, Johnson-Traver S
Tau is reduced in AD plasma and validation of employed ELISA methods.
Am J Neurodegener Dis. 2012;1(1):99-106. Epub 2012 May 15 PubMed: 23383382PAPER McLarnon JG
Microglial chemotactic signaling factors in Alzheimer's disease.
Am J Neurodegener Dis. 2012;1(3):199-204. PubMed: 23383392PAPER Cummings J, Gould H, Zhong K
Advances in designs for Alzheimer's disease clinical trials.
Am J Neurodegener Dis. 2012;1(3):205-16. PubMed: 23383393PAPER Marwarha G, Ghribi O
Leptin signaling and Alzheimer's disease.
Am J Neurodegener Dis. 2012;1(3):245-65. PubMed: 23383396PAPER O'Hagan TS, Wharton W, Kehoe PG
Interactions between oestrogen and the renin angiotensin system- potential mechanisms for gender differences in Alzheimer's disease.
Am J Neurodegener Dis. 2012;1(3):266-79. PubMed: 23383397PAPER Le MN, Kim W, Lee S, McKee AC, Hall GF
Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model.
Am J Neurodegener Dis. 2012;1(3):316-33. PubMed: 23383401Current Filters
No filters selected